Overview of Clinical Pharmacokinetics in Pediatrics: Possible Implications in Therapy (original) (raw)

Pharmacokinetics of drugs: newborn perspective

Sarfaraz Momin

Pediatric Medicine

View PDFchevron_right

Pharmacokinetics in the newborn

Jane Alcorn

Advanced Drug Delivery Reviews, 2003

View PDFchevron_right

A pharmacokinetic standard for babies and adults

Nick Holford

Journal of Pharmaceutical Sciences, 2013

View PDFchevron_right

Newborns, Older Children, and Adults Comparisons of Pharmacokinetics and Pharmacokinetic Variability

Robert Goble

View PDFchevron_right

Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults

Pilar Tejada

Pharmaceutics, 2011

View PDFchevron_right

Developmental Pharmacokinetics: Drug Disposition Relative to Age

Michelle Bestic

2014

View PDFchevron_right

Developmental paediatric anaesthetic pharmacology

Tom Hansen

Anaesthesia & Intensive Care Medicine, 2012

View PDFchevron_right

Introduction to the special issue on pharmacokinetics and pharmacodynamics in adolescents

Karen Hein

Journal of Adolescent Health, 1994

View PDFchevron_right

Pediatric pharmacology: current efforts and future goals to improve clinical practice

Elke Krekels

Expert Opinion on Drug Metabolism & Toxicology, 2015

View PDFchevron_right

Dosing in children

Nick Holford

Clinical Pharmacology and Therapeutics, 2010

View PDFchevron_right

Pharmacokinetic studies in children: recommendations for practice and research

Allison Needham

Archives of Disease in Childhood, 2018

View PDFchevron_right

A Pharmacokinetic and Pharmacodynamic Review

Carol Vetterly

Critical Care of Children with Heart Disease, 2009

View PDFchevron_right

Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling

francois bouzom

Fundamental & Clinical Pharmacology, 2008

View PDFchevron_right

Neonatal pharmacology—a practical approach

David mackintosh

Indian Journal of Pediatrics, 1986

View PDFchevron_right

Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children

Mélanie Wilbaux

Clinical Pharmacokinetics, 2015

View PDFchevron_right

Evaluation of Child/Adult Pharmacokinetic Differences from a Database Derived from the Therapeutic Drug Literature

Dale Hattis, Rob Goble

Toxicological Sciences, 2002

View PDFchevron_right

Determinants of Drug Metabolism in Early Neonatal Life

Gunnar Naulaers

Current Clinical Pharmacology, 2007

View PDFchevron_right

Therapeutic Drug Monitoring Is a Feasible Tool to Personalize Drug Administration in Neonates Using New Techniques: An Overview on the Pharmacokinetics and Pharmacodynamics in Neonatal Age

Cinzia Auriti

International Journal of Molecular Sciences

View PDFchevron_right

DRUGS IN INFANTS AND CHILDRENS

magendira mani vinayagam

View PDFchevron_right

Current pharmacotherapy in the newborn

Roberto Antonucci

Research and Reports in Neonatology, 2012

View PDFchevron_right

Drug Studies in Newborns: A Therapeutic Imperative

George Giacoia

Clinics in Perinatology, 2012

View PDFchevron_right

How to optimise drug study design: pharmacokinetics and pharmacodynamics studies introduced to paediatricians

Eric Vermeulen

Journal of Pharmacy and Pharmacology

View PDFchevron_right

Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs

Ramy Abdelrahman

Pharmaceutics, 2020

View PDFchevron_right

Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units

Siavosh Naji-Talakar

Expert Opinion on Drug Metabolism & Toxicology, 2021

View PDFchevron_right

Pharmacokinetics of Isoniazid in Low-Birth-Weight and Premature Infants

A. Hesseling

Antimicrobial Agents and Chemotherapy, 2014

View PDFchevron_right

Acetaminophen Developmental Pharmacokinetics in Premature Neonates and Infants

Tom Hansen

Anesthesiology, 2002

View PDFchevron_right

Biopharmaceutical considerations in paediatrics with a view to the evaluation of orally administered drug products – a PEARRL review

Maria Vertzoni

Journal of Pharmacy and Pharmacology, 2018

View PDFchevron_right

Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on anti-epileptics

Maria Donovan

British Journal of Clinical Pharmacology, 2015

View PDFchevron_right

Physiologically-based pharmacokinetic models for children: Starting to reach maturation?

Frans Russel

Pharmacology & Therapeutics, 2020

View PDFchevron_right

A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children

G A Woollard

British Journal of Clinical Pharmacology, 2000

View PDFchevron_right

Prediction of Clearance in Neonates and Infants ( 3 Months of Age) for Drugs That Are Glucuronidated: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling

Sharib Syed Muhammad

View PDFchevron_right

Improving Predictive Modeling in Pediatric Drug Development: Pharmacokinetics, Pharmacodynamics, and Mechanistic Modeling

Donald Mattison

Annals of the New York Academy of Sciences, 2005

View PDFchevron_right

General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in children

Anna-Karin Hamberg

British Journal of Clinical Pharmacology

View PDFchevron_right